---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-001858"
form_type: "8-K"
ticker: "PAYS"
cik: "0001496443"
company_name: "Paysign, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:42:48.137317+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Paysign Reports FY2024 Revenue of $58.38M and Acquires Gamma Innovation Assets

## Summary
- Full-year 2024 total revenues increased 23.5% to $58.38 million, with pharma patient affordability revenue up 214.5%.
- Full-year 2024 net income was $3.82 million ($0.07 per diluted share), down from $6.46 million in 2023 due to prior year tax benefit.
- Adjusted EBITDA rose 43.3% to $9.62 million, or $0.17 per diluted share, in 2024.
- Acquired assets of Gamma Innovation LLC for cash and 2.5M restricted shares vesting over four years, plus up to 500K earn-out shares.
- Appointed Michael Ngo, former Gamma managing member, as Chief Innovation Officer.

## SEC filing metadata
- accession: 0001683168-25-001858
- form_type: 8-K
- ticker: PAYS
- cik: 0001496443
- company_name: Paysign, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1496443/000168316825001858/0001683168-25-001858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1496443/000168316825001858/paysign_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-001858
- JSON: https://secwatch.observer/filing/0001683168-25-001858.json
- Plain text: https://secwatch.observer/filing/0001683168-25-001858.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.